Tests a brain implant for communication in adults with paralysis or ALS
Tests a brain implant's safety in adults with paralysis who cannot speak.
Key facts
- Who runs it
- Neuralink Corp
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
- Status
- Recruiting
- People taking part
- 6 people, planned
- Started
- 3 Oct 2025
- Expected to end
- Oct 2031
- Type of study
- Interventional
- Treatments tested
- N1 Implant
- R1 Robot
- Record updated
- 10 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 22 to 75 with ALS, PLS, stroke or spinal cord injury. They must have severe speech problems and weak arm and hand function.
- Age
- 22 Years to 75 Years
- Sex
- All sexes can join.
- Disease stage
- Diagnosis of ALS, PLS, stroke or spinal cord injury, with severe speech impairment and impaired upper limb function.
Main reasons for not taking part
- Moderate to high risk for serious problems during surgery
- Body Mass Index above 40
- Poorly controlled seizures or epilepsy
- Poorly controlled diabetes
- Acquired or hereditary immunosuppression
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Adults with diagnosis of ALS, PLS, stroke, or Spinal Cord Injury who have severe speech impairment and impaired upper limb function
- Life expectancy ≥ 12 months
- Ability to communicate in English
- Presence of a stable caregiver
Who cannot take part
- History of poorly controlled seizures or epilepsy
- History of poorly controlled diabetes
- Requires magnetic resonance imaging (MRI) for any ongoing medical conditions
- Psychiatric or psychological disorder
- Brain MRI demonstrating hemorrhage, tumor, distorted or adverse anatomy
- Any condition which, in the opinion of the Investigator, would compromise your ability to safely participate in the study or undergo the implantation procedure
- Moderate to high risk for serious perioperative adverse events
- Morbid obesity (Body Mass Index > 40)
- Acquired or hereditary immunosuppression
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 22 and 75 years old?
Where in United States
- The University of Texas Southwestern Medical CenterDallas, United StatesContact: Nader Pouratian, MDTaking people
About the trial
What the trial wants to find out
The VOICE Study is an early feasibility study to evaluate the initial clinical safety and efficacy of the N1 and R1 Systems device design concept in providing an ability to communicate. The Neuralink N1 Implant is intended to provide the ability to communicate to individuals with severe and irreversible speech production impairment. It is indicated for adults with neurological conditions of the central speech pathways who have impaired upper limb function. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.
The group in the trial
- Neuralink N1 Implant and R1 RobotTreatment being tested
Implantation of the N1 Implant by the R1 Robot.
Treatment: N1 Implant and R1 Robot
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
- Plain-language title
- Tests a brain implant for communication in adults with paralysis or ALSGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07224256, who can take part
- Record updated
- 10 November 2026